Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02604992 · ClinicalTrials.gov registry record · NA
Comparative Bioavailability of Dronabinol Oral Solution in Healthy Volunteers
A NA study, sponsored by INSYS Therapeutics.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
NCT02604992 is a NA study that has completed, run by INSYS Therapeutics. The registered enrollment target is 54 participants.
The verdict
NCT02604992, a NA study, has completed, sponsored by INSYS Therapeutics.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the comparative bioavailability of a test product of dronabinol oral solution administered under fed conditions to the reference listed drug (RLD) administered to participants under fed and fasted conditions. The secondary objective is to compare the onset of detectable dronabinol concentrations between dronabinol oral solution and the RLD.
Interventions
- DRUG Treatment A
- DRUG Treatment B
- DRUG Treatment C
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2015-11 |
| Est. Completion | 2015-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02604992
The ClinicalTrials.gov registry entry for NCT02604992 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is INSYS Therapeutics, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Treatment A is the first listed.
NCT02604992 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02604992 about?
NCT02604992 is a clinical study titled "Comparative Bioavailability of Dronabinol Oral Solution in Healthy Volunteers". The primary objective of this study is to evaluate the comparative bioavailability of a test product of dronabinol oral solution administered under fed conditions to the reference listed drug (RLD) administered to participants under fed and fasted conditions. The secondary objective is to compare t...
What is the current status of trial NCT02604992?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2015-11. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02604992?
The interventions under investigation include: Treatment A (DRUG), Treatment B (DRUG), Treatment C (DRUG).
Who is sponsoring clinical trial NCT02604992?
This trial is sponsored by INSYS Therapeutics, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.